Article | June 30, 2021

How Customer Forecasts Support The Integrity Of The Biopharma Supply Chain

Source: Cytiva
iStock-1254979961-forecast-outlook

The biopharmaceutical industry has been transformed by the adoption of new technologies and solutions. Changes such as digitizing operations through automation and robotics have improved product quality and improving efficiency. These new methods have also allowed for opportunities to meet the needs of smaller patient populations. With these new changes, it can be difficult for suppliers to plan for the level of demand expected from the industry during this rapid growth phase.

In addition, the COVID-19 pandemic has caused strains on supply chains, delays in production, and staff shortages, which means delays related to raw material and finished goods production. Before COVID, customer base level forecasts of demand were low, even with substantial resources and efforts dedicated to forecasting demand levels across their portfolio. Since manufacturing requirements and volumes are based on the level of customer demand, inaccurate forecasting levels can lead to vulnerabilities.

Learn more about Cytiva’s approach to supply risk management and tips on anticipating demand and accurate demand planning.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development